# HTG MOLECULAR DIAGNOSTICS, INC

HTG MOLECULAR DIAGNOSTICS, INC is a company headquartered in Tucson, AZ, United States.

## Company overview

- **Legal name:** HTG MOLECULAR DIAGNOSTICS, INC
- **Former names in filing history:** HTG MOLECULAR DIAGNOSTICS INC (2011-06-17 to 2012-11-14); HIGH THROUGHPUT GENOMICS INC (2002-03-01 to 2011-03-01)
- **Classification:** Company
- **Industry (SIC):** 3826 — Laboratory Analytical Instruments
- **Headquarters:** Tucson, AZ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001169987

## About

HTG MOLECULAR DIAGNOSTICS, INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001169987, and its reported industry is Laboratory Analytical Instruments. In 10-K filed on 2023-03-30, it reported annual revenue of USD 6,366,220; net income of USD -21,594,476; total assets of USD 17,777,655 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $6.4M (USD 6,366,220)
- **Net income:** -$21.6M (USD -21,594,476)
- **Total assets:** $17.8M (USD 17,777,655)
- **Cash and equivalents:** $12.2M (USD 12,210,857)
- **Operating cash flow:** -$18.4M (USD -18,407,791)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $8.9M (USD 8,906,828)
- **Net income:** -$17.1M (USD -17,145,170)
- **Total assets:** $30.5M (USD 30,460,687)
- **Cash and equivalents:** $9.6M (USD 9,599,950)
- **Operating cash flow:** -$16.5M (USD -16,508,554)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $8.5M (USD 8,548,864)
- **Net income:** -$20.9M (USD -20,870,218)
- **Total assets:** $35.2M (USD 35,197,908)
- **Cash and equivalents:** $22.4M (USD 22,397,812)
- **Operating cash flow:** -$16.3M (USD -16,292,377)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $19.2M (USD 19,203,888)
- **Net income:** -$19.3M (USD -19,297,664)
- **Total assets:** $45.1M (USD 45,119,269)
- **Cash and equivalents:** $7.6M (USD 7,619,748)
- **Operating cash flow:** -$16.7M (USD -16,695,936)

## Recent SEC filings

- Form 8-K — filed 2023-06-08 — period 2023-06-06 — 8-K
- Form 8-K — filed 2023-06-05 — period 2023-06-01 — 8-K
- Form 8-K — filed 2023-05-24 — period 2023-05-18 — 8-K
- Form 8-K — filed 2023-05-16 — period 2023-05-16 — 8-K
- Form 10-Q — filed 2023-05-11 — period 2023-03-31 — 10-Q
- Form 8-K — filed 2023-05-10 — period 2023-05-10 — 8-K
- Form 8-K — filed 2023-04-25 — period 2023-04-25 — 8-K
- Form 10-K — filed 2023-03-30 — period 2022-12-31 — 10-K
- Form 8-K — filed 2023-02-03 — period 2023-02-02 — 8-K
- Form SC 13G — filed 2023-02-03
- Form 8-K — filed 2023-01-06 — period 2023-01-06 — 8-K
- Form 8-K — filed 2022-12-29 — period 2022-12-29 — 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/htg-molecular-diagnostics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology